Dosing algorithms for vitamin K antagonists across VKORC1 and CYP2C9 genotypes

Author(s):
Baranova, E.V.; Verhoef, T.I.; Ragia, G.; Cessie, S. le (0000-0003-2154-4923); Asselbergs, F.W.; Boer, A. de; Manolopoulos, V.G.; Maitland-van der Zee, A.H.; EU-PACT Grp
Published
2017
Publication type
Article / Letter to editor
acenocoumaroldrug dosing biomarkerspharmacogeneticsphenprocoumonrandomized controlled trial
Date issued
2017-03-31
Language
English
Is part of
Journal of Thrombosis and Haemostasis (2017), Vol. 15, no. 3, p. 465-472
hdl
1887/115526
doi
10.1111/jth.13615